Editas Medicine, Inc. (EDIT) — Institutional Holders, Q2 2026 (page 3)

217 institutional investment managers reported a EDIT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $386.4M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 217. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

EDIT 13F holders ranked 201–217 of 217

Institutional investors reporting a position in Editas Medicine, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Parallel Advisors#201 · 60 sh$194.000.0%
DT Investment Partners#202 · 54 sh$175.000.0%
MCF Advisors#203 · 54 sh$175.000.0%
Gen-Wealth Partners#204 · 53 sh$172.000.0%
Center for Financial Planning#205 · 50 sh$162.000.0%
EVOLUTION WEALTH MANAGEMENT#206 · 50 sh$162.000.0%
North Star Investment Management#207 · 38 sh$123.000.0%
Colonial Advisors#208 · 30 sh$97.000.0%
Hilton Head Capital Partners#209 · 27 sh$87.000.0%
Essential Investment Partners#210 · 20 sh$65.000.0%
RAFFA WEALTH MANAGEMENT#211 · 19 sh$62.000.0%
CoreCap Advisors#212 · 15 sh$49.000.0%
Financial Perspectives#213 · 6 sh$19.000.0%
JPL Wealth Management#214 · 4 sh$13.00New
HANTZ FINANCIAL SERVICES#215 · 100 sh$0.000.0%
Covestor Ltd#216 · 108 sh$0.00+71.4%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#217 · 1,378 sh—-74.2%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.